跳至主要内容
临床试验/IRCT2016092529963N1
IRCT2016092529963N1已完成3 期

Evaluation of the efficacy of Spinal-Z with conventional chemotherapy on the survival of gastric and esophageal cancer patients: A randomized clinical trial

Vice chancellor for research ,Digestive Diseases Research Institute, Tehran University of Medical Sc0 个研究点目标入组 83 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
83

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Histologically confirmed esophageal squamous cell carcinoma or Adenocarcinoma of the distal esophagus or gastric cancer; The Largest diameter of the lesion = 10 mm based on Spiral-CT Scan; The absence of brain metastases; Karnofsky Performance status scale =70%; Age>=18
  • Exclusion criteria:
  • Congestive heart failure (EF <= 40%); Medical history of myocardial infarction during the past 6 months; Concurrent use of Vasodilators; Uncontrolled arrhythmias; Complications in central nervous system (Spinal cord and brain); Medical history of CVA, stroke within the last 6 months; Respiratory failure (PO2<= 50 mmHg) for any reason; Level of liver enzymes (AST, ALT) > 5 folds the normal limits; Bilirubin serum = 5 mg per deciliter; serum Creatinine level > 2 milligrams per deciliter); WBC < 2500 per cubic millimeter of blood; Platelet count < 100,000 per cubic millimeter of blood ; Pregnant and nursing mothers; Any type of active infection ; IV drug users ; Major psychological disorders

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research ,Digestive Diseases Research Institute, Tehran University of Medical Sc

相似试验